World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Dietrich CG, Geier A, Merle U. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? World J Gastroenterol 2023; 29(2): 367-377 [PMID: 36687116 DOI: 10.3748/wjg.v29.i2.367]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i2/367.htm

(172) (175) (0) (0) (0) (9) (5574) (21)

Number	Citing Articles
1	Avishek Mandal. Prospective Coronavirus Liver Effects: Available Knowledge. Annals of Clinical Gastroenterology and Hepatology 2023; 7(1) doi: 10.29328/journal.acgh.1001039
2	Fernanda Manhães Pozzobon, Ronir Raggio Luiz, Júlia Gomes Parente, Taísa Melo Guarilha, Maria Paula Raymundo Cunha Fontes, Renata de Mello Perez, Maria Chiara Chindamo. Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?. Journal of Clinical Medicine 2024; 13(9) doi: 10.3390/jcm13092687
3	Pan Yan, Rui Li, Xiao-Yan Yuan, Yong Wang, Li-Juan Lan, Xiao-Ping Yu, Da-Feng Liu. Dynamic immune response and its influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study. World Journal of Hepatology 2026; 18(2): 113004 doi: 10.4254/wjh.v18.i2.113004 Abstract(155) \| Core Tip(83) \| Full Article(HTML)(302) \| Full Article (PDF)-2319K(86) \| Full Article with Cover (PDF)-2591K(137) \| Full Article (XML)-232K(54) \| Audio-1512K(10) \| Peer-Review Report-194K(35) \| Answering Reviewers-101K(47) \| Times Cited (1) \| Total Visits (830) \| Open
4	Yunkoo Kang, Yeonjae Park, Hong Koh. Risk of complications in adulthood following childhood metabolic dysfunction-associated steatohepatitis based on Korean national health insurance data. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-025-97229-3
5	J. Collin Fishman, Christina Qian, Yestle Kim, Hannah Rochon, Shelagh M. Szabo, Rosie Sun, Michael Charlton. Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study. Journal of Managed Care & Specialty Pharmacy 2024; 30(9) doi: 10.18553/jmcp.2024.24069
6	Samuel Salazar-García, Eunice Lares-Villaseñor, Juan Manuel Vargas-Morales. Assessment of biochemical and hematological profiles in outpatients with serological evidence of SARS-CoV-2 infection. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1778397
7	Ludovico Abenavoli, Isabella Aquila, Matteo Antonio Sacco, Giuseppe Guido Maria Scarlata, Anna Caterina Procopio, Luigi Boccuto, Emidio Scarpellini, Marta Greco, Daniela Patrizia Foti, Pietrantonio Ricci, Francesco Luzza. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series. Diseases 2023; 11(4) doi: 10.3390/diseases11040141
8	О. О. Чукур, Н. В. Пасєчко, А. О. Боб. КОРЕКЦІЯ ТИРЕОЇДНОЇ ДИСФУНКЦІЇ ТА МЕТАБОЛІЧНИХ ПОРУШЕНЬ У ЖІНОК ПЕРИМЕНОПАУЗАЛЬНОГО ВІКУ З ГІПОТИРЕОЗОМ. Здобутки клінічної і експериментальної медицини 2023; (4) doi: 10.11603/1811-2471.2023.v.i4.14310
9	Michele Walsh, Deborah John, Nicole Peritore, Andrea Morris, Carolyn Bird, Marion Ceraso, Sarah Eichberger, Rachel Novotny, Laura Stephenson, Suzanne Stluka, Roberta Riportella. Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All. Journal of Human Sciences and Extension 2018; doi: 10.54718/RYTE6013
10	Сауле Абусофияновна Алиева, Игорь Геннадиевич Никитин, Ирина Витальевна Васильева. КЛИНИКО-ЛАБОРАТОРНАЯ ХАРАКТЕРИСТИКА ТЕЧЕНИЯ COVID-19 У ГОСПИТАЛИЗИРОВАННЫХ ПАЦИЕНТОВ С НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНЬЮ ПЕЧЕНИ . University therapeutic journal 2025; 7(1) doi: 10.56871/UTJ.2025.91.44.001
11	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1 Abstract(1159) \| Core Tip(1120) \| Full Article(HTML)(4885) \| Full Article (PDF)-407K(323) \| Full Article with Cover (PDF)-1825K(414) \| Full Article (Word)-130K(57) \| Full Article (XML)-119K(208) \| Audio-14227K(37) \| Peer-Review Report-222K(217) \| Answering Reviewers-194K(172) \| Times Cited (0) \| Total Visits (5887) \| Open
12	Є. С. Сірчак, А. В. Стегура. ОЦІНКА ЕФЕКТИВНОСТІ КОМПЛЕКСНОЇ ТЕРАПІЇ ІЗ ВИКОРИСТАННЯМ ПРОБІОТИКА ТА РЕБАМІПІДУ НА ДИНАМІКУ БІОЛОГІЧНИХ МАРКЕРІВ УРАЖЕННЯ КИШЕЧНИКА ТА ДИСБІОТИЧНІ ЗМІНИ У ХВОРИХ НА НЕАЛКОГОЛЬНУ ЖИРОВУ ХОРОБУ ПЕЧІНКИ ПІСЛЯ СOVID-19. Здобутки клінічної і експериментальної медицини 2023; (4) doi: 10.11603/1811-2471.2023.v.i4.14309
13	Mohamad Abdelkhalik, Samah Al Tawil, Adam El Fouani, Nour Allakiss, Lama Mattar, Wissam H. Faour, Rajaa Chatila, Aleksandra Klisic. Unveiling metabolic dysfunction-associated fatty liver disease: Knowledge gaps and attitudes among Lebanese university students. PLOS ONE 2024; 19(8) doi: 10.1371/journal.pone.0306825
14	Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler. Cholesterol and Cholesterol-Lowering Medications in COVID-19—An Unresolved Matter. International Journal of Molecular Sciences 2024; 25(19) doi: 10.3390/ijms251910489
15	Jorge Quarleri, M Victoria Delpino. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage. World Journal of Hepatology 2024; 16(1): 1-11 doi: 10.4254/wjh.v16.i1.1 Abstract(779) \| Core Tip(883) \| Full Article(HTML)(2820) \| Full Article (PDF)-1204K(255) \| Full Article with Cover (PDF)-11949K(298) \| Full Article (Word)-610K(47) \| Full Article (XML)-236K(178) \| Audio-1342K(11) \| Peer-Review Report-230K(193) \| Answering Reviewers-97K(174) \| Times Cited (5) \| Total Visits (4177) \| Open
16	S. A. Alieva, I. G. Nikitin, I. V. Vasilyeva. Clinical features of COVID-19 in hospitalized patients with non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2025; (2) doi: 10.31146/1682-8658-ecg-234-2-52-61
17	Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, Hafsah Alim Ur Rahman, Lubna Najmi, Mah I Kan Changez, Muhammad Moiz Javed, Md Al Hasibuzzaman. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review. World Journal of Hepatology 2024; 16(8): 1185-1198 doi: 10.4254/wjh.v16.i8.1185 Abstract(613) \| Core Tip(694) \| Full Article(HTML)(2640) \| Full Article (PDF)-605K(182) \| Full Article with Cover (PDF)-2631K(205) \| Full Article (XML)-181K(154) \| Audio-649K(11) \| Peer-Review Report-172K(149) \| Answering Reviewers-186K(143) \| Supplementary Material-19K(139) \| Times Cited (0) \| Total Visits (4156) \| Open
18	Xue Ma, Chun-Yong Sun, Yan Zhang, Jia Li, Dong-Sheng Zhao. The hepatoprotective effect of Lonicera japonica Flos on rats with high-fat diet-induced non-alcoholic fatty liver disease. Fitoterapia 2025; 183 doi: 10.1016/j.fitote.2025.106516
19	Neues zur Fettleber: Nomenklatur, Screening-Empfehlungen, Therapiebemühungen und andere klinisch relevante Aspekte. Zeitschrift für Gastroenterologie 2023; 61(10) doi: 10.1055/a-2149-7976
20	Dhanvee Balaji, Ranjith Balakrishnan, Dhasarathdev Srinivasan, Rajasekaran Subbarayan, Rupendra Shrestha, Nityanand Srivastava, Ankush Chauhan. The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments. Infectious Microbes and Diseases 2024; 6(4) doi: 10.1097/IM9.0000000000000161
21	Israel Rico-Alba, Alberto Retana-Guzmán, Marcela Agudelo-Botero, Claudio Alberto Dávila-Cervantes. Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study. Annals of Hepatology 2026; 31(2) doi: 10.1016/j.aohep.2026.102224